Metoclopramide. Management of gastrointestinal intolerance in rheumatoid arthritis patients
- PMID: 7254112
Metoclopramide. Management of gastrointestinal intolerance in rheumatoid arthritis patients
Abstract
Ten patients with rheumatoid arthritis who were unable to tolerate anti-inflammatory doses of non-steroidal anti-inflammatory drugs (NSAIDs) were admitted to the study. After endoscopy three patients were taken out of the study because of frank gastric ulceration. Seven patients entered the six-week study during which anti-inflammatory doses of NSAIDs were preceded by 30 minutes by a 10-mg dose of oral metoclopramide. The insults of this pilot study suggest that pretreatment with metoclopramide enables patients with rheumatoid arthritis who have non-ulcer dyspepsia to tolerate full dosage of NSAIDs.
Similar articles
-
Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis.Q J Med. 1986 Jan;58(225):53-8. Q J Med. 1986. PMID: 3704106
-
Fenbufen in patients with gastric intolerance.Eur J Rheumatol Inflamm. 1982;5(3):301-3. Eur J Rheumatol Inflamm. 1982. PMID: 7084291
-
Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.Arch Intern Med. 1996 Jul 22;156(14):1530-6. Arch Intern Med. 1996. PMID: 8687261
-
Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S14-8. Ital J Gastroenterol Hepatol. 1999. PMID: 10379464 Review.
-
Clinical experience with cyclooxygenase-2 inhibitors.Rheumatology (Oxford). 2002 Apr;41 Supp 1:16-22; discussion 35-42. Rheumatology (Oxford). 2002. PMID: 12173276 Review.
Cited by
-
Metoclopramide. An updated review of its pharmacological properties and clinical use.Drugs. 1983 May;25(5):451-94. doi: 10.2165/00003495-198325050-00002. Drugs. 1983. PMID: 6345129 Review.
MeSH terms
Substances
LinkOut - more resources
Medical